Sam-A Pharm. Co., Ltd (KOSDAQ: 009300)

Market Cap	111.39B
Revenue (ttm)	102.55B
Net Income (ttm)	24.74B
Shares Out	6.10M
EPS (ttm)	4,054.18
PE Ratio	4.50
Forward PE	n/a
Dividend	750.00 (4.02%)
Ex-Dividend Date	Dec 27, 2024

Volume	64,016
Open	19,150
Previous Close	19,440
Day's Range	18,250 - 19,150
52-Week Range	15,520 - 37,950
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 300
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2023, Sam-A Pharm.'s revenue was 97.21 billion, an increase of 18.99% compared to the previous year's 81.70 billion. Earnings were 21.37 billion, an increase of 79.44%.